Form 4: InspireMD Director Roubin Receives Restricted Stock Grant

InspireMD, Inc. Director Gary S. Roubin was granted 88,053 shares of restricted common stock, vesting in January 2027.

Summary

• Director Gary S. Roubin of InspireMD, Inc. acquired 88,053 shares of common stock on January 14, 2026.
• These shares are restricted stock and will vest on January 14, 2027, contingent upon Mr. Roubin's continued service to the company.
• The acquisition price for these shares was $0, indicating a grant rather than a purchase.
• Following this transaction, Mr. Roubin beneficially owns a total of 744,478 shares of common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is a standard compensation practice that aligns the director's interests with those of shareholders, indicating continued commitment. This is generally viewed as a neutral to slightly positive event for corporate governance and long-term alignment.

Positives

• The grant of restricted stock aligns Director Gary S. Roubin's interests with those of the shareholders, incentivizing long-term performance.
• The transaction is a standard form of non-cash compensation, preserving company cash reserves.

Negatives

• The shares are restricted and do not provide immediate liquidity or full ownership to the director until the vesting date.
• Vesting is subject to continued service, meaning the shares could be forfeited if the director's service ceases before January 14, 2027.

Risks

• The vesting of the 88,053 restricted shares is contingent on Director Gary S. Roubin's continued service to InspireMD, Inc. until January 14, 2027, posing a risk of forfeiture if service is terminated.
• The value of the granted shares is subject to the future market price of InspireMD, Inc. common stock, which can fluctuate.

Future Outlook

The grant of restricted stock to Director Gary S. Roubin indicates an ongoing commitment to his role and aligns his future financial interests with the long-term performance of InspireMD, Inc. The shares are expected to vest in January 2027, assuming continued service.

Industry Context

The grant of restricted stock to a director is a common and widely accepted practice in publicly traded companies across various industries. It serves as a key component of executive and director compensation packages, designed to attract and retain talent while aligning their incentives with shareholder value creation.

Comparison to Industry Standards

• The use of restricted stock as a compensation tool for directors is a standard practice, comparable to compensation structures at other public companies in the medical device or biotechnology sectors.
• The vesting schedule, typically over one to several years, is also consistent with industry norms for incentivizing long-term commitment and performance.

Related Party Transactions

• Director Gary S. Roubin received a grant of 88,053 shares of restricted common stock from InspireMD, Inc. as compensation, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with long-term shareholder value, potentially leading to more focused decision-making.
• Employees: No direct impact on general employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• The 88,053 restricted shares are scheduled to vest on January 14, 2027, subject to Gary S. Roubin's continued service.

Key Dates

Recommendation

The grant of restricted stock to a director is a routine compensation event that aligns management interests with shareholders but does not provide new fundamental information to warrant a change in investment recommendation based solely on this filing. It reinforces the director's commitment but does not alter the company's operational or financial outlook.

Keywords

InspireMD, NSPR, Gary S. Roubin, Form 4, restricted stock, stock grant, director compensation, beneficial ownership, insider transaction